9.44
-0.15(-1.56%)
Currency In USD
Previous Close | 9.59 |
Open | 9.64 |
Day High | 9.76 |
Day Low | 9.27 |
52-Week High | 14.44 |
52-Week Low | 4.93 |
Volume | 991,190 |
Average Volume | 1.02M |
Market Cap | 810.84M |
PE | -16.56 |
EPS | -0.57 |
Moving Average 50 Days | 10.32 |
Moving Average 200 Days | 9.29 |
Change | -0.15 |
If you invested $1000 in Anavex Life Sciences Corp. (AVXL) 10 years ago, it would be worth $1,573.33 as of August 20, 2025 at a share price of $9.44. Whereas If you bought $1000 worth of Anavex Life Sciences Corp. (AVXL) shares 5 years ago, it would be worth $2,160.18 as of August 20, 2025 at a share price of $9.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025
GlobeNewswire Inc.
Aug 05, 2025 11:30 AM GMT
Webcast and Conference Call To be Held Tuesday, August 12, 2025, 8:30 am ETNEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on deve
Anavex Life Sciences Announces Positive Precision Medicine Results from up to 4-Years of Oral Blarcamesine Treatment in Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s Disease
GlobeNewswire Inc.
Jul 31, 2025 11:30 AM GMT
New clinical Precision Medicine population data demonstrates up to 84.6 Weeks (19.5 Months) ‘time saved’ by early-start ADAS-Cog13 difference: −5.43 (P = 0.0035), ADCS-ADL difference: +9.50 (P < 0.0001) Restoring impaired autophagy as early event, pr
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
GlobeNewswire Inc.
May 14, 2025 11:30 AM GMT
H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ and H.C. Wainwright 6th Annual Neuro Perspectives ConferenceNEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clin